ANIK Anika Therapeutics PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ANIK
- PE Ratio
The current P/E ratio of ANIK can't be determined, as the TTM EPS of -$3.87 is negative. The most recent PE ratio recorded for Anika Therapeutics was 123.55 in December 2021.
ANIK PE ratio history
Over the last ten years, the average PE ratio of Anika Therapeutics has been 28.37. In the past ten years, ANIK's PE ratio reached its highest point in the Dec 2021 quarter at 123.55, with a price of $35.83 and an EPS of $0.29. The Mar 2020 quarter saw the lowest point at 14.31, with a price of $28.91 and an EPS of $2.02.
Anika Therapeutics PE ratio by year
Maximum annual increase: 134.02% in 2013
Maximum annual decrease: -40.28% in 2014
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $16.46 | -$3.83 |
| 2023 | N/A | N/A | $22.66 | -$5.64 |
| 2022 | N/A | N/A | $29.6 | -$1.02 |
| 2021 | 123.55 | N/A | $35.83 | $0.29 |
| 2020 | N/A | N/A | $45.26 | -$1.69 |
| 2019 | 26.87 | 3.95% | $51.85 | $1.93 |
| 2018 | 25.85 | 4.53% | $33.61 | $1.3 |
| 2017 | 24.73 | 12.15% | $53.91 | $2.18 |
| 2016 | 22.05 | 19.06% | $48.96 | $2.22 |
| 2015 | 18.52 | 18.64% | $38.16 | $2.06 |
| 2014 | 15.61 | -40.28% | $40.74 | $2.61 |
| 2013 | 26.14 | 134.02% | $38.16 | $1.46 |
| 2012 | 11.17 | -25.93% | $9.94 | $0.89 |
| 2011 | 15.08 | -23.14% | $9.8 | $0.65 |
| 2010 | 19.62 | -17.7% | $6.67 | $0.34 |
Anika Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $15.03 | -$3.87 |
| Dec 2024 | N/A | N/A | $16.46 | -$3.83 |
| Sep 2024 | N/A | N/A | $24.7 | -$6.65 |
| Jun 2024 | N/A | N/A | $25.33 | -$5.07 |
| Mar 2024 | N/A | N/A | $25.4 | -$5.25 |
| Dec 2023 | N/A | N/A | $22.66 | -$5.64 |
| Sep 2023 | N/A | N/A | $18.63 | -$1.69 |
| Jun 2023 | N/A | N/A | $25.98 | -$1.53 |
| Mar 2023 | N/A | N/A | $28.72 | -$1.54 |
| Dec 2022 | N/A | N/A | $29.6 | -$1.02 |
| Sep 2022 | N/A | N/A | $23.8 | -$1.09 |
| Jun 2022 | N/A | N/A | $22.32 | -$0.76 |
| Mar 2022 | N/A | N/A | $25.11 | -$0.11 |
| Dec 2021 | 123.55 | N/A | $35.83 | $0.29 |
| Sep 2021 | N/A | N/A | $42.56 | -$0.41 |
ANIK Price vs fair value
ANIK average PE ratio chart
ANIK PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| HALO Halozyme Therapeutics Inc | 14.07 | $6.67B |
| JNJ Johnson & Johnson | 17.2 | $374.99B |
| MDT Medtronic plc | 26.76 | $113.59B |
| SYK Stryker Corp | 50.81 | $145.64B |
| STAA Staar Surgical Co | N/A | $857.79M |
| ANIK Anika Therapeutics Inc | N/A | $158.76M |
Frequently asked questions
What is Anika Therapeutics's PE ratio?
The current price to earnings ratio of ANIK can't be calculated, as its EPS of -$3.87 is negative.
What is the highest PE ratio for ANIK?
The highest quarterly PE ratio in the last ten years has been 123.55 and it was in the Dec 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.